Sunesis Pharmaceuticals Q3 EPS $(0.06) Beats $(0.08) Estimate

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 66.67 percent increase over losses of $(0.18) per share

Benzinga · 11/12/2019 21:12

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 66.67 percent increase over losses of $(0.18) per share from the same period last year.